Amedisys Inc (AMED)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	2,236,382	2,227,658	2,229,409	2,234,331	2,223,199	1,671,704	1,667,201	1,111,979	573,337	567,158	15,793	33,153	518,223	1,014,511	1,507,022	1,979,978	1,955,633	1,889,333	1,810,011	1,726,487
Total assets	US$ in thousands	2,060,170	2,027,420	1,982,400	1,946,960	1,976,240	1,982,130	2,000,990	1,908,390	1,856,970	1,937,640	1,599,560	1,573,210	1,567,200	1,602,720	1,645,490	1,440,080	1,262,740	1,212,380	1,205,860	1,184,240
Total asset turnover		1.09	1.10	1.12	1.15	1.12	0.84	0.83	0.58	0.31	0.29	0.01	0.02	0.33	0.63	0.92	1.37	1.55	1.56	1.50	1.46

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,236,382K ÷ $2,060,170K
= 1.09

Amedisys Inc.'s total asset turnover ratio has been relatively stable over the past eight quarters, ranging from 1.09 to 1.16. This ratio indicates the company's efficiency in generating sales revenue relative to its total assets.

A total asset turnover ratio of over 1 suggests that Amedisys is effectively utilizing its assets to generate sales. The gradual increase in the ratio from Q4 2022 to Q1 2023 indicates improved efficiency in asset utilization, reaching a peak of 1.16. This could be a positive sign of increased productivity and effectiveness in the company's operations during that period.

Overall, the trend in Amedisys Inc.'s total asset turnover suggests that the company has been maintaining a healthy balance between its asset base and revenue generation, demonstrating efficient management of resources to drive sales.